Yoshihiro Hayakawa

Prof. Yoshihiro Hayakawa

Division of Pathogenic Biochemistry, Department of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Japan
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2006 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
MSMark J. Smyth
Mark J. Smyth
Lineage differentiation and the formation of heterogeneous mature subsets are crucial for immune cells to maintain a breadth of responsiveness to pathogens while controlling reactivity to self. In this study, we report that CD27 is a key marker of the NK cell lineage, dissecting the mature Mac-1high NK cell pool into two functionally distinct subsets. The CD27low NK cell subset possesses a higher threshold to stimulation and appears to be tightly regulated by the expression of NK cell inhibitory receptors. Comparatively, the CD27high NK cell subset displays a greater effector function, exhibits a distinct tissue distribution and responsiveness to chemokines, and interacts productively with dendritic cells. Importantly, we have verified that CD27high and CD27low subsets with distinct cell surface phenotypes also exist in human peripheral blood. These findings clearly reclassify mature NK cells into two distinct subsets and begin to discern their specific role in immune responses.

1 November 2002 in Nature Reviews Cancer
Verified
Journal Article
Closed access
MSMark J. Smyth
Mark J. Smyth
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
KTKazuyoshi Takeda
Kazuyoshi Takeda
HYHideo Yagita
Hideo Yagita

1 January 2001 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
KTKazuyoshi Takeda
Kazuyoshi Takeda
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
MSMark J. Smyth
Mark J. Smyth
NKNobuhiko Kayagaki
Nobuhiko Kayagaki
NYNoriko Yamaguchi
Noriko Yamaguchi
KOKo Okumura
Ko Okumura

1 February 2005 in Molecular Immunology
Verified
Journal Article
Closed access
MSMark J. Smyth
Mark J. Smyth
ECErika Cretney
Erika Cretney
JKJanice M. Kelly
Janice M. Kelly
JWJennifer A. Westwood
Jennifer A. Westwood
SSShayna E.A. Street
Shayna E.A. Street
YHYoshihiro Hayakawa
Yoshihiro Hayakawa

2 May 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KTKazuyoshi Takeda
Kazuyoshi Takeda
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
Luc Van KaerLuc Van Kaer
Luc Van Kaer
HMHironori Matsuda
Hironori Matsuda
HYHideo Yagita
Hideo Yagita
KOKo Okumura
Ko Okumura
Natural killer T (NKT) cells constitute a distinct subpopulation of T cells with a unique antigen specificity, prompt effector functions, and an unusual tissue distribution. NKT cells are especially abundant in the liver, but their physiological function in this organ remains unclear. In the present study, we examined the possible contribution of NKT cells to a murine model of hepatitis induced by i.v. injection of Con A. CD1-deficient mice lacking NKT cells were highly resistant to Con A-induced hepatitis. Adoptive transfer of hepatic NKT cells isolated from wild-type mice, but not from FasL-deficientgldmice, sensitized CD1-deficient mice to Con A-induced hepatitis. Furthermore, adoptive transfer of hepatic mononuclear cells from wild-type mice, but not from CD1-deficient mice, sensitizedgldmice to Con A-induced hepatitis. Upon Con A administration, hepatic NKT cells rapidly up-regulated cell surface FasL expression and FasL-mediated cytotoxicity. At the same time, NKT cells underwent apoptosis leading to their rapid disappearance in the liver. These results implicated FasL expression on liver NKT cells in the pathogenesis of Con A-induced hepatitis, suggesting a similar pathogenic role in human liver diseases such as autoimmune hepatitis.

14 January 2002 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KTKazuyoshi Takeda
Kazuyoshi Takeda
MSMark J. Smyth
Mark J. Smyth
ECErika Cretney
Erika Cretney
YHYoshihiro Hayakawa
Yoshihiro Hayakawa
NKNobuhiko Kayagaki
Nobuhiko Kayagaki
KOKo Okumura
Ko Okumura
Natural killer (NK) cells and interferon (IFN)-γ have been implicated in immune surveillance against tumor development. Here we show that tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) plays a critical role in the NK cell–mediated and IFN-γ–dependent tumor surveillance. Administration of neutralizing monoclonal antibody against TRAIL promoted tumor development in mice subcutaneously inoculated with a chemical carcinogen methylcholanthrene (MCA). This protective effect of TRAIL was at least partly mediated by NK cells and totally dependent on IFN-γ. In the absence of TRAIL, NK cells, or IFN-γ, TRAIL-sensitive sarcomas preferentially emerged in MCA-inoculated mice. Moreover, development of spontaneous tumors in p53+/− mice was also promoted by neutralization of TRAIL. These results indicated a substantial role of TRAIL as an effector molecule that eliminates developing tumors.